Pharmacotherapy for acute pouchitis - PubMed (original) (raw)

Review

. 2011 Sep;45(9):1127-37.

doi: 10.1345/aph.1P790. Epub 2011 Jul 20.

Affiliations

• PMID: 21775695
• DOI: 10.1345/aph.1P790

Review

Pharmacotherapy for acute pouchitis

Geoffrey C Wall et al. Ann Pharmacother. 2011 Sep.

Abstract

Objective: To review the current literature concerning the medical treatment of acute and chronic pouchitis.

Data sources: MEDLINE and International Pharmaceutical Abstracts were searched (both 1965-February 2011) using the following terms: pouchitis, Crohn's, ulcerative colitis, diagnosis, prophylaxis, and treatment. Bibliographies from key articles were also searched, and all pertinent articles were reviewed.

Study selection and data extraction: All available primary literature published in English on treatment for pouchitis was considered, with controlled trials receiving highest priority.

Data synthesis: Pouchitis occurs in up to 50% of ileal pouch-anal anastomosis (IPAA) patients with inflammatory bowel disease within 10 years of the procedure. Symptoms include abdominal pain, bloating, and fecal incontinence with frequent diarrhea. The diagnosis of pouchitis is usually made based on symptoms as well as endoscopic and histologic findings. Treatment of acute pouchitis includes antimicrobials such as ciprofloxacin, metronidazole, and rifaximin. If these fail, limited data suggest that oral budesonide, mesalamine, or infliximab may be effective treatments. Surgical revision may be necessary if medical treatments fail. Emerging evidence suggests that the probiotic compound VSL#3 may be effective in preventing the recurrence of pouchitis.

Conclusions: Pouchitis is a common complication of IPAA surgery. The strongest data suggest that antimicrobial therapy is an effective first-line treatment for acute pouchitis, and VSL#3 may be effective for prevention of recurrence.

PubMed Disclaimer

Similar articles

• [Diagnosis and medical treatment of pouchitis in ileal pouch-anal anastomosis in patients with ulcerative colitis].
  Okazaki K, Matsushita M, Kawamata S, Shimatani M, Fujii T. Okazaki K, et al. Nihon Rinsho. 2005 May;63(5):885-9. Nihon Rinsho. 2005. PMID: 15881186 Review. Japanese.
• [Probiotics--should we change the treatment strategy for pouchitis?].
  Klinge LG, Kjeldsen J. Klinge LG, et al. Ugeskr Laeger. 2006 Oct 9;168(41):3516-8. Ugeskr Laeger. 2006. PMID: 17059804 Review. Danish.
• Management of pouch dysfunction or pouchitis with an ileoanal pouch.
  Gionchetti P, Morselli C, Rizzello F, Romagnoli R, Campieri M, Poggioli G, Laureti S, Ugolini F, Pierangeli F. Gionchetti P, et al. Best Pract Res Clin Gastroenterol. 2004 Oct;18(5):993-1006. doi: 10.1016/j.bpg.2004.07.003. Best Pract Res Clin Gastroenterol. 2004. PMID: 15494291 Review.
• Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
  McLaughlin SD, Clark SK, Bell AJ, Tekkis PP, Ciclitira PJ, Nicholls RJ. McLaughlin SD, et al. Dis Colon Rectum. 2009 May;52(5):879-83. doi: 10.1007/DCR.0b013e3181a4f9fa. Dis Colon Rectum. 2009. PMID: 19502851
• Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis.
  Alexander F, Sarigol S, DiFiore J, Stallion A, Cotman K, Clark H, Lydzinski B, Fazio V. Alexander F, et al. J Pediatr Surg. 2003 Jan;38(1):78-82. doi: 10.1053/jpsu.2003.50015. J Pediatr Surg. 2003. PMID: 12592624

Cited by

• Medical treatment of pouchitis: a guide for the clinician.
  Rabbenou W, Chang S. Rabbenou W, et al. Therap Adv Gastroenterol. 2021 Jun 27;14:17562848211023376. doi: 10.1177/17562848211023376. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34249146 Free PMC article. Review.
• Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome.
  Distrutti E, Cipriani S, Mencarelli A, Renga B, Fiorucci S. Distrutti E, et al. PLoS One. 2013 May 15;8(5):e63893. doi: 10.1371/journal.pone.0063893. Print 2013. PLoS One. 2013. PMID: 23691109 Free PMC article.
• The role of probiotics and prebiotics in inducing gut immunity.
  Vieira AT, Teixeira MM, Martins FS. Vieira AT, et al. Front Immunol. 2013 Dec 12;4:445. doi: 10.3389/fimmu.2013.00445. Front Immunol. 2013. PMID: 24376446 Free PMC article. Review.
• Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases.
  Cheng FS, Pan D, Chang B, Jiang M, Sang LX. Cheng FS, et al. World J Clin Cases. 2020 Apr 26;8(8):1361-1384. doi: 10.12998/wjcc.v8.i8.1361. World J Clin Cases. 2020. PMID: 32368530 Free PMC article. Review.
• Outcomes and Management of the Ileal Pouch-Anal Anastomosis in the Elderly.
  Zhou JQ, Duenas SM, Kirat T, Remzi F, Chang S. Zhou JQ, et al. Curr Treat Options Gastroenterol. 2018 Sep;16(3):275-288. doi: 10.1007/s11938-018-0184-0. Curr Treat Options Gastroenterol. 2018. PMID: 29998454 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon